BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25319653)

  • 21. Cell internalization SELEX: in vitro selection for molecules that internalize into cells.
    Yan A; Levy M
    Methods Mol Biol; 2014; 1103():241-65. PubMed ID: 24318899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress on the development of the strategies for siRNAs delivery in vivo].
    Tang D; Mao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of aptamers for targeted therapeutics.
    Ray P; Viles KD; Soule EE; Woodruff RS
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aptamers as targeted therapeutics: current potential and challenges.
    Zhou J; Rossi J
    Nat Rev Drug Discov; 2017 Mar; 16(3):181-202. PubMed ID: 27807347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Charnet A; Morris MC; Aldrian-Herrada G; Heitz F; Divita G
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):44-6. PubMed ID: 17233597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long dsRNA-mediated RNA interference and immunostimulation: a targeted delivery approach using polyethyleneimine based nano-carriers.
    Sajeesh S; Lee TY; Hong SW; Dua P; Choe JY; Kang A; Yun WS; Song C; Park SH; Kim S; Li C; Lee DK
    Mol Pharm; 2014 Mar; 11(3):872-84. PubMed ID: 24521200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.
    Ma Y; Li W; Zhou Z; Qin X; Wang D; Gao Y; Yu Z; Yin F; Li Z
    Bioconjug Chem; 2019 Mar; 30(3):536-540. PubMed ID: 30702869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in aptamer screening and small molecule aptasensors.
    Kim YS; Gu MB
    Adv Biochem Eng Biotechnol; 2014; 140():29-67. PubMed ID: 23851587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells.
    Sioud M
    Methods Mol Biol; 2009; 487():61-82. PubMed ID: 19301642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers as artificial gene regulation elements.
    Suess B; Weigand JE
    Methods Mol Biol; 2009; 535():201-8. PubMed ID: 19377994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
    Zhu Q; Shibata T; Kabashima T; Kai M
    Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer mediated siRNA delivery.
    Chu TC; Twu KY; Ellington AD; Levy M
    Nucleic Acids Res; 2006 Jun; 34(10):e73. PubMed ID: 16740739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photomodulating Gene Expression by Using Caged siRNAs with Single-Aptamer Modification.
    Zhang L; Chen C; Fan X; Tang X
    Chembiochem; 2018 Jun; 19(12):1259-1263. PubMed ID: 29488297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.